Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

Richmond-based Phlow Corp. has promoted Dan Hackman from chief business officer to president, the pharmaceutical manufacturing company announced Thursday. Hackman joined Phlow in 2020. He previously ...

Earlier this week, the U.S. government awarded a $354 million contract to a new public benefit company called Phlow to make generics that are in short supply during the pandemic. The move, which ...

RICHMOND, Va., May 19, 2020 /PRNewswire/ -- Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing ...

Richmond pharmaceutical company Phlow is looking to raise up to $50 million in outside funding. The round puts the company at a pre-money valuation of $230 million.

“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.